SARAH KAPPA

Concepts (108)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Ewing
4
2026
121
1.330
Why?
Bone Neoplasms
5
2026
455
1.160
Why?
Venous Thromboembolism
1
2026
190
0.790
Why?
Osteosarcoma
1
2026
275
0.780
Why?
Sex Characteristics
1
2018
324
0.490
Why?
Health Behavior
1
2018
389
0.450
Why?
Cancer Survivors
1
2018
270
0.430
Why?
Feeding Behavior
1
2018
717
0.380
Why?
Anemia, Sickle Cell
3
2020
324
0.340
Why?
Emergency Service, Hospital
3
2024
1208
0.280
Why?
Hydroxyurea
2
2020
87
0.280
Why?
Sarcoma, Small Cell
1
2025
2
0.230
Why?
Desmoplastic Small Round Cell Tumor
1
2025
12
0.230
Why?
Adolescent
12
2026
20817
0.210
Why?
Menorrhagia
1
2024
81
0.200
Why?
Pneumatosis Cystoides Intestinalis
1
2012
8
0.180
Why?
Anemia, Iron-Deficiency
1
2024
141
0.180
Why?
Mesenchymoma
1
2011
3
0.170
Why?
Humerus
1
2011
16
0.170
Why?
Child, Preschool
5
2026
15018
0.160
Why?
Stem Cell Transplantation
1
2012
234
0.160
Why?
Transplantation, Homologous
1
2012
674
0.160
Why?
Ultrasonography, Doppler, Transcranial
1
2019
113
0.150
Why?
Child
9
2026
26220
0.140
Why?
Drug Prescriptions
1
2020
230
0.140
Why?
Ovarian Neoplasms
1
2012
452
0.130
Why?
Texas
1
2026
3622
0.130
Why?
Infant
5
2026
13332
0.130
Why?
Algorithms
1
2024
1686
0.130
Why?
Graft vs Host Disease
1
2012
685
0.120
Why?
Patient Compliance
1
2019
468
0.120
Why?
Cerebrovascular Circulation
1
2019
487
0.120
Why?
Cardiomyopathies
1
2011
517
0.120
Why?
Female
13
2026
70720
0.120
Why?
Patient Education as Topic
1
2018
456
0.110
Why?
Genome, Human
1
2011
1323
0.100
Why?
Retrospective Studies
5
2026
17760
0.100
Why?
Mass Screening
1
2019
807
0.100
Why?
Male
9
2026
64766
0.100
Why?
Genome-Wide Association Study
1
2011
1842
0.100
Why?
Yersinia
1
2013
5
0.100
Why?
Gene Expression Regulation
1
2011
2345
0.100
Why?
Humans
15
2026
130962
0.090
Why?
Chromosomes, Human, Pair 22
1
2012
97
0.090
Why?
Chromosomes, Human, Pair 7
1
2012
77
0.090
Why?
DNA Mismatch Repair
1
2011
45
0.090
Why?
Risk Factors
1
2026
11022
0.090
Why?
Stroke
1
2019
1056
0.090
Why?
Bone Diseases
1
2011
48
0.090
Why?
Histiocytosis, Sinus
1
2011
34
0.090
Why?
Hospitalization
1
2020
1935
0.080
Why?
Cadherins
1
2011
176
0.080
Why?
Translocation, Genetic
1
2012
348
0.080
Why?
Crohn Disease
1
2013
291
0.080
Why?
Internship and Residency
1
2020
1217
0.080
Why?
Germ-Line Mutation
1
2011
373
0.070
Why?
Oncogene Proteins, Fusion
2
2025
244
0.070
Why?
Fatal Outcome
2
2012
362
0.060
Why?
RNA-Binding Protein EWS
1
2025
39
0.060
Why?
Colorectal Neoplasms
1
2011
631
0.060
Why?
Adenocarcinoma
1
2011
988
0.050
Why?
Combined Modality Therapy
2
2012
1241
0.050
Why?
Salpingectomy
1
2012
15
0.050
Why?
Ovariectomy
1
2012
159
0.040
Why?
Electron Transport Complex III
1
2011
4
0.040
Why?
Purkinje Fibers
1
2011
7
0.040
Why?
Digestive System Surgical Procedures
1
2012
87
0.040
Why?
Orthopedic Procedures
1
2012
81
0.040
Why?
Disease Management
1
2024
563
0.040
Why?
District of Columbia
1
2019
16
0.040
Why?
Follow-Up Studies
2
2019
5246
0.040
Why?
Down-Regulation
1
2011
654
0.040
Why?
Radiography
1
2011
753
0.040
Why?
Antisickling Agents
1
2018
19
0.040
Why?
Quality Improvement
1
2024
703
0.030
Why?
RNA
1
2011
517
0.030
Why?
Practice Guidelines as Topic
1
2024
1298
0.030
Why?
Myocardium
1
2011
865
0.030
Why?
DNA
1
2011
1413
0.030
Why?
Prognosis
1
2024
4950
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
1325
0.030
Why?
Registries
1
2011
1608
0.030
Why?
Gene Expression Profiling
1
2011
1846
0.030
Why?
Yersinia pseudotuberculosis
1
2013
6
0.020
Why?
Yersinia enterocolitica
1
2013
10
0.020
Why?
Genes, Bacterial
1
2013
217
0.020
Why?
Abnormal Karyotype
1
2012
8
0.020
Why?
Incidence
1
2019
3360
0.020
Why?
DNA, Bacterial
1
2013
491
0.020
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2011
66
0.020
Why?
DNA, Neoplasm
1
2012
285
0.020
Why?
In Situ Hybridization, Fluorescence
1
2012
752
0.020
Why?
Anti-Bacterial Agents
1
2012
2550
0.020
Why?
Disease-Free Survival
1
2012
901
0.020
Why?
Postoperative Complications
1
2012
3133
0.020
Why?
Adrenal Cortex Hormones
1
2011
333
0.020
Why?
Intestinal Mucosa
1
2013
768
0.020
Why?
Infant, Newborn
1
2011
8568
0.020
Why?
Immunohistochemistry
1
2011
1598
0.020
Why?
Young Adult
2
2013
10016
0.020
Why?
Neoplasm Staging
1
2011
1307
0.020
Why?
Bacterial Proteins
1
2013
940
0.020
Why?
Treatment Outcome
1
2012
12957
0.010
Why?
Diagnosis, Differential
1
2011
1896
0.010
Why?
Case-Control Studies
1
2013
3417
0.010
Why?
United States
1
2020
11852
0.010
Why?
Biomarkers, Tumor
1
2012
1619
0.010
Why?
Tomography, X-Ray Computed
1
2011
2116
0.010
Why?
KAPPA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (108)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_